ISRCTN64621295已完成不适用
Efficacy of addition of high-risk human papillomavirus (hrHPV) testing by Hybrid Capture II to conventional cytological screening for cervical cancer
SALTRO - Doctor Laboratory & Thrombosis Service (The Netherlands)0 个研究点目标入组 25,000 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women invited for the cervical cancer screening program (aged 30 - 60 years)
- •2. General practitioner affiliated with SALTRO laboratory
排除标准
- •1. Not called for screening, i.e., ages under 30 years, or over 60 years
- •2. Follow-up of previous non-normal cytology within the current screening round of the program, i.e., abnormal cytology or lesion greater than or equal to CIN3 less than 2 years before inclusion
- •3. Current pregnancy
- •4.Status after extirpation of the uterus or amputation of the portio
研究者
相似试验
招募中
不适用
The efficacy evaluation of the human papillomavirus (HPV) testing in primary cervix cancer screeningCervix cancerJPRN-UMIN000014720School of Medicine, Keio University50,000
进行中（未招募）
不适用
HPV infection clearance with glucan and probioticsISRCTN62596811Ospedale dei Bambini Vittore Buzzi80
已完成
不适用
Efficacy of quadrivalent human papillomavirus vaccine (Gardasil) for recurrent respiratoru papillomatosisrecurrent respiratory papillomatosisJPRN-UMIN000020352Kanazawa University5
招募中
1 期
Human papillomavirus vaccine effectiveness study among men who have sex with meHPV infection, Prevention of HPV infection among healthy participants.CTIS2022-502224-49-00Geneeskundige En Gezondheidsdienst Amsterdam730
已完成
不适用
The Canadian Cervical Cancer Screening Trial of human papillomavirus (HPV) testing versus Pap cytologyCancerISRCTN57612064McGill University (Canada) - Research Grants Office10,154